In 2010, the US Food and Drug Administration (FDA) cleared femtosecond laser systems for cataract surgery. Available in 2011, this technology has the potential to significantly impact cataract surgery.
Femtosecond lasers offer surgeons the ability to make very precise cuts in a targeted area without damaging the surrounding tissues. This technology has already dramatically changed refractive surgery and is poised to do the same for cataract surgery. Three companies, OptiMedica, LenSx (acquired by Alcon in September 2010), and LensAR, in different stages of FDA clearance, are developing femtosecond laser systems for cataract surgery. These systems will create the initial corneal incisions, capsulotomy, and also fragment the lens.
This article outlines the advantages of femtosecond laser cataract surgery and provides an initial comparison of the LensAR, LenSx/Alcon, and OptiMedica systems and early clinical results.
aDepartment of Ophthalmology, Stanford University, Stanford, USA
bOptiMedica Corporation, Santa Clara, California, USA
cBascom Palmer Eye Institute, University of Miami, Miami, Florida, USA
Correspondence to William Culbertson, MD, Bascom Palmer Eye Institute, University of Miami, 900 NW, 17th Street, Miami, FL 33136, USA Tel: +1 305 333 7439; e-mail: email@example.com